Our blog

What life science companies should consider for a US expansion
What life science companies should consider for a US expansion
by James Chippindale
Posted in Life Sciences, Pharmaceuticals
Are you a life science company looking to expand into the US? To find out more about what you should consider, we interviewed Joanne Farquharson, President & Chief Executive Officer at Foothold America, a company that helps businesses around the world to expand into the US market.
Read more
Attracting and Retaining Talent during the Turnover Tsunami
Attracting and Retaining Talent during the Turnover Tsunami
by Christine Sands
Posted in Pharmaceuticals
In the US, we are beginning to see the start of the predicted ‘turnover tsunami’ and it might not be long until we see something similar across Europe and the UK. But why is this happening and what can employers do to not only retain existing employees but to also attract those individuals looking for a change of career?
Read more
CASE STUDY: Generic Pharma Company’s US Expansion
CASE STUDY: Generic Pharma Company’s US Expansion
by Christine Sands
Posted in Case Studies, Pharmaceuticals
An established pharmaceutical company in Europe that develops, manufactures and markets generic medications planned to continue its growth strategy by opening a new subsidiary to target the US generics market. To develop and commercialise a portfolio of generic drugs to market, the company needed a US General Manager.
Read more
How to Manage Impostor Syndrome
How to Manage Impostor Syndrome
by Revna Cömertpay
Posted in Life Sciences
Have you ever felt like you are out of your depth or can’t do the job you’ve been hired to do? Do you worry you will be discovered at any point as a ‘fraud’? You may be suffering from impostor syndrome: a phenomenon where an individual doubts their skills, talents, abilities, and accomplishments in the face of obvious success.
Read more
Will Covid-19 increase US biosimilar adoption in 2021?
Will Covid-19 increase US biosimilar adoption in 2021?
by Christine Sands
Posted in Pharmaceuticals
In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?
Read more
Interview with Elizabeth A Crocker | CEO & Data Protection Officer | CLEWS Medical Limited
Interview with Elizabeth A Crocker | CEO & Data Protection Officer | CLEWS Medical Limited
by Andrew Maddison
Posted in MedTech, Women Revolutionizing
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Elizabeth A Crocker – Chief Executive Officer & Data Protection Officer at CLEWS Medical Limited – about her career journey from her early days as a nurse, to owning her own business to now leading the commercial direction of a Med Tech startup.
Read more
Interview with Céline Crochet | Services Manager | Thermo Fisher Scientific
Interview with Céline Crochet | Services Manager | Thermo Fisher Scientific
by Revna Cömertpay
Posted in Life Sciences, Women Revolutionizing
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Céline Crochet – Services Manager at Thermo Fisher Scientific – who told us the achievements she is proud of as a manager and how she manages to balance her career with being a single mum.
Read more
Interview with Dr Melissa Toyos | MD Partner | Toyos Clinic
Interview with Dr Melissa Toyos | MD Partner | Toyos Clinic
by Tanya Ridding
Posted in MedTech, Women Revolutionizing
As part of our ‘Female Leaders: Inspiring Together' series, we interviewed Dr Melissa Toyos – MD Partner of Toyos Clinic – about her career journey as an ophthalmic surgeon and why managing work-life balance means accepting you can't do everything.
Read more